PROTHENA CORP PUBLIC LTD CO - 8-K Filing
Bristol Myers Squibb terminates PRX019 global license agreement following strategic review
Tickers: $PRTA
Bristol Myers Squibb terminates PRX019 global license agreement following strategic review
Tickers: $PRTA